FA
DFTX

Fiduciary Alliance’s Definium Therapeutics DFTX Stock Holding History

Fiduciary Alliance’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$282K Buy
+6,000
New +$148K 0.02% 454

Other funds holding DFTX

PFA
Peak Financial Advisors Denver, Colorado $242M AUM 19.63% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
BRG
Bay Rivers Group Williamsburg, Virginia $293M AUM 48.17% 1-Year Est. Return
SCI
Stableford Capital II Scottsdale, Arizona $289M AUM 20.84% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
CSP
Cary Street Partners Richmond, Virginia $4.58B AUM 24% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
WPW
Waldron Private Wealth Bridgeville, Pennsylvania $2.89B AUM 23.18% 1-Year Est. Return

Fiduciary Alliance's DFTX Position: Q2 2026 in Review

Fiduciary Alliance opened a new position in Definium Therapeutics (DFTX) in Q2 2026: 6,000 shares worth $282K. The stake represents 0.02% of the portfolio and ranks #454 among its holdings.

22 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • Fiduciary Alliance held 6,000 shares of Definium Therapeutics worth $282K as of Q2 2026.
  • Definium Therapeutics was a new Fiduciary Alliance position in Q2 2026.
  • Definium Therapeutics made up 0.02% of Fiduciary Alliance's portfolio in Q2 2026, its #454 holding.
  • 22 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Fiduciary Alliance's 13F filing for Q2 2026, filed 20 Jul 2026.